Buy or sell 4D Molecular Therapeutics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Request Access
View More Companies

4D Molecular Therapeutics Stock

4D Molecular Therapeutics’ mission is to design and develop transformative gene therapy products using our proprietary.

About 4D Molecular Therapeutics Stock

4D Molecular Therapeutics, we are unlocking the full potential of the gene therapy field. Our customized AAV vectors can deliver genes to any cell in the body to eradicate disease.

Funding History

August 2015$7.0M
September 2017$3.0M

Management

Co-Founder

David Schaffer

COO

Anthony Davies

Co-Founder, President & CEO

David Kirn

Press

Other Companies

Bayer Logo
Learn More
Learn More
Bayer
Multinational pharmaceutical and life sciences company
157Age (years)
$3.0BTotal Funding
Bolt Biotherapeutics Logo
Learn More
Learn More
Bolt Biotherapeutics
Bolt Therapeutics plans to develop a novel format for T-cell mediated anti-tumour therapy.
6Age (years)
$84.0MTotal Funding
Finch Therapeutics Group Logo
Learn More
Learn More
Finch Therapeutics Group
Finch Therapeutics Group is a microbiome therapeutics company, develops microbial therapies serving patients with serious.
17Age (years)
$41.6MTotal Funding
Galera Therapeutics Logo
Learn More
Learn More
Galera Therapeutics
Therapeutic agents for preventing damage due to radiation treatment of cancer
12Age (years)
$149MTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from 4D Molecular Therapeutics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 190K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo